Obesity News

Medindia's Press Release’ section provides the latest press release on Obesity from across the world for the global audience. This page links to 480 Obesity press releases.

Nation's Only Boarding School for Teen Obesity, Gem Academy, shares lessons on its third Anniversary

The nation's first solution-based treatment program exclusively devoted to helping high school aged girls who struggle with obesity celebrates its third anniversary of treatment outcomes that are changing lives. PHOENIX , Jan. 6, 2022 ...


Expert Advice on Blood Sugar and Weight Management

CALGARY, AB , Dec. 23, 2021 /PRNewswire/ -- Sugar has a much larger impact on the body than most people think, including many wellness consultants. Sugars come in different sizes and each breaks down differently in the body, but the risk ...

Obesity Action Coalition (OAC) President and CEO, Joe Nadglowski, Issues Statement on Trust for America's Health's 2021 State of Obesity Report and Center for Disease Control and Prevention's State-Specific 2020 Data on Adult Obesity Prevalence

TAMPA, Fla. , Sept. 16, 2021 /PRNewswire/ -- "Yesterday, Trust for America's Health released their annual State of Obesity Report and the CDC released their State-Specific Data on obesity prevalence. As expected, obesity worsened across many ...

Weight Loss Surgery Importance Underlined by Study Showing the Health Dangers of All Obesity, says West Medical

The Southern California-based medical group comments on a recent article that the risks all obese patients face are significant, but medical intervention can lead to a better quality of life. LOS ANGELES , Aug. 5, 2021 /PRNewswire-PRWeb/ ...

Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity

Building on recent findings from the Regeneron Genetics Center, novel small molecule drug candidates will target GPR75 to potentially address obesity and related co-morbidities TARRYTOWN, N.Y. , July 27, 2021 /PRNewswire/ -- Regeneron ...

Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Glucagon-like Peptide-1 and Glucagon Receptor Dual Agonist in Overweight or Obese Chinese Participants at the American Diabetes Association's 81st Scientific Sessions

SAN FRANCISCO and SUZHOU, China , June 24, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...

Novo Nordisk receives FDA approval for Wegovy™ to treat adults with obesity based on unprecedented efficacy for a prescription medicine in clinical trials

- Despite being recognized by leading authorities as a serious disease, obesity remains stigmatized, resulting in patients being underdiagnosed and significantly undertreated PLAINSBORO, N.J. , June 4, 2021 /PRNewswire/ -- Novo Nordisk ...

Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office

LAUSANNE , Switzerland , May 24, 2021 /PRNewswire/ -- Gnubiotics Sciences SA (Gnubiotics), a Swiss biotech company pioneering novel microbiome targeted solutions for humans and companion animals, today announced the allowance from the ...

Obesity Risks Associated with Likely Endemic Health Concerns Spur Options Medical Weight Loss Expansion

Florida-based Medical Weight Loss Franchise Grows to Answer National Demand in Fight Against the Lingering Impact of the Pandemic ST. PETERSBURG, Fla. , May 21, 2021 /PRNewswire-PRWeb/ -- Options Medical Weight Loss, a successful medical ...

Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities

BAGSVÆRD, Denmark , May 13, 2021 /PRNewswire/ -- Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with ...

Obesity News »

Diet and Lifestyle Crisis Fuels India's Abdominal Obesity

Diet and Lifestyle Crisis Fuels India's Abdominal Obesity

Soumya Swaminathan, former WHO Chief Scientist, highlights that the rise in abdominal obesity in India is largely due to unhealthy diets and a lack of physical activity, pointing to a significant public health concern ( ). ...

Muscle Risk in Weight-Loss Medication

Muscle Risk in Weight-Loss Medication

Essential need to preserve skeletal muscle mass when using GLP-1 receptor agonists for weight loss has been highlighted in the Lancet editorial. Although effective for obesity treatment, these medications raise concerns over the potential for ...

Expanding Access to Weight Loss Drugs Could Save Lives

Expanding Access to Weight Loss Drugs Could Save Lives

Expanding access to new and highly effective weight-loss medications could save over 40,000 deaths every year in the United States ( ). A recent study by the Yale School of Public Health and the University of Florida, explains the ...

Simple Blood Test Offers Early Detection of Obesity-Related Risks in Kids

Simple Blood Test Offers Early Detection of Obesity-Related Risks in Kids

New blood test has been developed that measures lipids to identify children at risk of obesity-related complications, including type 2 diabetes , liver disease , and heart disease , as per a study from King’s College London published in Nature ...

Obesity Care Crisis: Underfunded Services Limiting Access to Treatment

Obesity Care Crisis: Underfunded Services Limiting Access to Treatment

A BMJ investigation has uncovered a widespread lack of access to obesity care in England. Nearly half of the country's patients cannot see specialist weight loss teams, and...

More Obesity News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.